Nuveen Asset Management LLC lowered its stake in TriMas Co. (NASDAQ:TRS - Free Report) by 24.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 114,974 shares of the industrial products company's stock after selling 37,681 shares during the quarter. Nuveen Asset Management LLC owned about 0.28% of TriMas worth $2,827,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of the stock. Bank of America Corp DE lifted its position in shares of TriMas by 127.3% in the fourth quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company's stock worth $86,400,000 after purchasing an additional 1,967,738 shares in the last quarter. Bellecapital International Ltd. acquired a new position in shares of TriMas in the fourth quarter valued at about $29,160,000. Raymond James Financial Inc. acquired a new position in shares of TriMas in the fourth quarter valued at about $6,698,000. Kennedy Capital Management LLC grew its stake in shares of TriMas by 94.8% in the fourth quarter. Kennedy Capital Management LLC now owns 485,721 shares of the industrial products company's stock valued at $11,944,000 after acquiring an additional 236,346 shares in the last quarter. Finally, Advisory Research Inc. grew its stake in TriMas by 41.2% during the fourth quarter. Advisory Research Inc. now owns 754,089 shares of the industrial products company's stock worth $18,543,000 after buying an additional 220,000 shares in the last quarter. Institutional investors own 99.42% of the company's stock.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on TRS shares. Wall Street Zen upgraded shares of TriMas from a "hold" rating to a "buy" rating in a research note on Sunday. BWS Financial restated a "buy" rating and set a $40.00 price target on shares of TriMas in a report on Wednesday, April 30th.
Read Our Latest Analysis on TRS
TriMas Trading Down 2.4%
Shares of TRS stock traded down $0.63 during trading hours on Wednesday, hitting $25.74. 192,640 shares of the company were exchanged, compared to its average volume of 334,341. The firm has a market cap of $1.05 billion, a P/E ratio of 40.22 and a beta of 0.58. TriMas Co. has a fifty-two week low of $19.33 and a fifty-two week high of $28.51. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83. The company has a 50 day simple moving average of $23.31 and a two-hundred day simple moving average of $24.02.
TriMas (NASDAQ:TRS - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.03. TriMas had a net margin of 2.93% and a return on equity of 9.21%. The business had revenue of $241.67 million during the quarter, compared to the consensus estimate of $235.41 million. During the same quarter last year, the firm posted $0.37 EPS. TriMas's revenue was up 6.4% compared to the same quarter last year. Equities analysts anticipate that TriMas Co. will post 1.69 EPS for the current year.
TriMas Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, May 13th. Shareholders of record on Tuesday, May 6th were issued a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.62%. The ex-dividend date was Tuesday, May 6th. TriMas's dividend payout ratio is 20.78%.
Insider Transactions at TriMas
In related news, Director Shawn Sedaghat purchased 72,937 shares of the firm's stock in a transaction dated Thursday, May 22nd. The shares were purchased at an average cost of $26.16 per share, for a total transaction of $1,908,031.92. Following the completion of the transaction, the director now directly owns 1,883,758 shares in the company, valued at approximately $49,279,109.28. This represents a 4.03% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Scott A. Mell sold 2,218 shares of the business's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $22.54, for a total value of $49,993.72. Following the transaction, the chief financial officer now directly owns 26,288 shares of the company's stock, valued at $592,531.52. The trade was a 7.78% decrease in their position. The disclosure for this sale can be found here. Insiders have acquired 1,770,195 shares of company stock worth $43,736,754 in the last ninety days. Company insiders own 14.20% of the company's stock.
TriMas Profile
(
Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Stories

Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report